regulatory
confidence high
sentiment negative
materiality 0.55
Nasdaq Panel grants Exicure listing extension until Nov 14, 2024; debt-to-equity swap completed
EXICURE, INC.
- Extension granted on Sept 17, 2024; must evidence compliance with all continued listing criteria by Nov 14, 2024.
- Previously regained compliance with Nasdaq minimum bid price requirement.
- Exchanged ~$1M of indebtedness for equity at $3.00 per share.
- Company working to satisfy Panel terms; risk of delisting remains if not compliant by deadline.